NSECommittee Meeting Updates28 Aug 2026 · 28 Aug 2026, 11:33 pm

Committee Meeting Updates

Gujarat Themis Biosyn Limited · GUJTHEM

✦ AI Summary▲ PositiveFundraise

Gujarat Themis Biosyn Limited has informed the Exchange regarding Outcome of Committee Meeting held on August 28, 2026 for allotment of 2,11,86,440 Equity Shares to eligible QIBs at the issue price of Rs. 354 per Equity Share, aggregating to Rs. 749,99,99,760.

Analysis Scores

Earnings Impact8/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk4/10
Balance Sheet Risk5/10
Liquidity Impact9/10
Market Sentiment8/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Gujarat Themis Biosyn Limited has informed the Exchange regarding Outcome of Committee Meeting held on August 28, 2026 for allot

Attachments (1)

📄

GUJARATTHEMIS_28082026233225_outcome3rdFRCM28082026.pdf

pdf

Download →
View document text
GUJARAT THEMIS BIOSYN LIMITED CIN: L24230GJ1981PLC004878 REGD. OFFICE & FACTORY: 69/C GIDC INDUSTRIAL ESTATE, VAPI – 396 195, DIST. VALSAD, GUJARAT, INDIA TEL: 0260-2430027 / 2400639, E-mail: hrm@gtbl.in.net August 28, 2026 Listing Department Department of Corporate Services National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block-G Phiroze Jeejeebhoy Towers, Dalal Street Bandra Kurla Complex Mumbai - 400001 Bandra East, Mumbai 400051 Symbol: GUJTHEM Scrip Code: 506879 Dear Sir/Madam, Re: Qualified institutions placement (“QIP” or “Issue”) of equity shares of face value of Rs. 1 each (the “Equity Shares”) to qualified institutional buyers (“QIBs”) Sub: Outcome of the meeting of the Fund-Raising Committee. In furtherance to our earlier intimation with respect to the Issue which opened on August 25, 2026 and closed on August 28, 2026, we wish to inform you that the Fund Raising Committee of the Company at its meeting held today, i.e. August 28, 2026, approved the issue and allotment of 2,11,86,440 Equity Shares, to eligible QIBs at the issue price of Rs. 354 per Equity Share (including a premium of Rs. 353 per Equity Share), which includes a discount of Rs. 18.57 ie 4.98% of the floor price, as determined in terms of SEBI ICDR Regulations)], aggregating to Rs. 749,99,99,760, pursuant to the QIP. Pursuant to the allotment of Equity Shares under the QIP, the paid-up equity share capital of the Company stands increased from Rs. 10,89,65,265 consisting of 10,89,65,265 Equity Shares of face value of Rs. 1 each to Rs. 13,01,51,705 consisting of 13,01,51,705 Equity Shares of face value of Rs. 1 each. The shareholding pattern of the Company before and after the Issue, will be submitted along with listing application in the format specified in Regulation 31 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The information as required under Regulation 30 of the SEBI Listing Regulations read with Schedule – III part- A to the SEBI Listing Regulations to read with the Securities and Exchange Board of India circular no. SEBI/HO/CFD/CFDPoD1/P/CIR/2023/123 dated July 13, 2023, SEBI master circular no. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026 is as follows: Type of securities issued and allotted (viz. equity Equity Shares shares, convertibles etc.) Type of issuance (further public offering, rights Qualified Institutions Placement issue, depository receipts (ADR/GDR), qualified institutions placement, preferential allotment etc.) GUJARAT THEMIS BIOSYN LIMITED Total no. of securities issued or the total amount 2,11,86,440 Equity Shares at an issue price for which the securities have been issued of Rs. 354 per Equity Share (including a (approximately) p remium of Rs. 353 per Equity Share). Total amount for which securities were issued Rs. 749,99,99,760/- The Fund-Raising Committee meeting commenced at 10:15 p.m. and the meeting was concluded at 10:30 p.m. Further find attached herewith the list of allottees who have been allotted more than 5 per cent of the Equity Shares of the Issue size marked as Annexure A. We request you to take the above on record pursuant to compliance under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. Thanking you Yours faithfully For Gujarat Themis Biosyn Limited Vineet Gawankar Company Secretary & Compliance Officer Encl.: As above GUJARAT THEMIS BIOSYN LIMITED Annexure A LIST OF ALLOTTEES WHO HAVE BEEN ALLOTTED MORE THAN 5 PER CENT OF THE EQUITY SHARES OFFERED IN THE QIP No. of Sr % of Total Name of the Allottees Shares Category No Issue Allotted QUANT MUTUAL FUND - QSIF EQUITY EX TOP 1 15,00,000 7.08% MUTUAL FUND - MF 100 LONG-SHORT FUND QUANT MUTUAL FUND - QSIF HYBRID LONG- 2 5,75,100 2.71% MUTUAL FUND - MF SHORT FUND QUANT MUTUAL FUND - QSIF ACTIVE ASSET 3 7,50,000 3.54% MUTUAL FUND - MF ALLOCATOR LONG - SHORT FUND QUANT MUTUAL FUND - QSIF SECTOR 4 93,000 0.44% MUTUAL FUND - MF ROTATION LONG - SHORT FUND QUANT MUTUAL FUND - QUANT EQUITY 5 1,18,644 0.56% MUTUAL FUND - MF SAVINGS FUND QUANT MUTUAL FUND - QUANT SMALL CAP 6 54,37,833 25.67% MUTUAL FUND - MF FUND INSURANCE COMPANY KOTAK MAHINDRA LIFE INSURANCE 7 28,24,859 13.33% REGISTERED WITH COMPANY LTD. IRDAI BANK OF INDIA MANUFACTURING & 8 2,82,486 1.33% MUTUAL FUND - MF INFRASTRUCTURE FUND 9 BANK OF INDIA SMALL CAP FUND 8,47,458 4.00% MUTUAL FUND - MF 10 BANK OF INDIA FLEXI CAP FUND 7,06,215 3.33% MUTUAL FUND - MF 11 BANK OF INDIA MULTI CAP FUND 2,82,486 1.33% MUTUAL FUND - MF 12 CAPRI GLOBAL CAPITAL LIMITED 14,12,430 6.67% SI - NBFC FOREIGN PORTFOLIO 13 SAINT CAPITAL FUND 11,29,944 5.33% INVESTOR (CORPORATE) FOREIGN PORTFOLIO 14 AYUSHMAT LTD 24,01,130 11.33% INVESTOR (CORPORATE) For Gujarat Themis Biosyn Limited Vineet Gawankar Company Secretary & Compliance Officer